Company intelligence / Profile preview

Evolution Devices

Oakland, California, United Statesevolutiondevices.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Evolution Devices has developed the EvoWalk system—an AI-powered wearable that uses functional electrical stimulation to restore walking ability in patients with neurological impairments. The device received FDA 510(k) clearance in January 2024. Clinical feedback highlights improved mobility and quality of life for users with conditions like multiple sclerosis and stroke. The company also offers the EvoVision system for advanced gait analysis used by clinics and research institutions.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (Functional Electrical Stimulation)Digital health platform
Industry: Therapeutic Medical Devices

Partnerships

Collaborates with universities/hospitals using EvoVision system

Beyond the preview

Go deeper on Evolution Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evolution Devices.

Explore the full profile